From my understanding, apabetalone could be prescribed for off-label use. However, it could not be marketed for off-label use. My understanding is that to market for a new indication that is not already approved, a new Phase 3 and application to FDA or similar agency would be required. Prescribing and marketing are two different animals.
BearDownAZÂ